Sino Biological announced on November 24 that the company and Suzhou National Hi-Tech District (SND) Management Committee signed Project Investment Agreement on November 23, 2021. The company plans to set up a Southern R&D center and a testing service center focusing on biological product cell quality and biosafety testing in SND. The total investment in the first phase of the project is not less than CNY 50 million. SND will provide about 3,636.07 square meters of workshops for company leasing, and support policies such as rental subsidies, industry incentives, equipment subsidies, and talent incentives according to the agreement.

Sino Biological said that the completion of this project will help the company expand business scale, enhance profitability and comprehensive competitiveness.

Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.

Sino Biological is committed to providing high-quality recombinant protein and antibody reagents and to being a one-stop technical services shop for life science researchers around the world.